Gonorrhea Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies – Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics

Posted on
by

Gonorrhea Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics
Gonorrhea Market Trends
DelveInsight’s “Gonorrhea Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Gonorrhea, historical and forecasted epidemiology as well as the Gonorrhea market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Gonorrhea – Market Insights, Epidemiology, and Market Forecast-2032”.

Some of the key facts of the Gonorrhea Market Report:

  • As per CDC, the gonorrhea rate among males increased 6.0% (200.8 to 212.8 cases per 100,000 males) and the rate among females increased 3.6% (140.7 to 145.8 cases per 100,000 females). During 2014–2018, the rate among males increased 78.7% (119.1 to 212.8 cases per 100,000 males) and the rate among females increased 45.2% (100.4 to 145.8 cases per 100,000 females) in the US. 

Key benefits of the report:

  1. Gonorrhea market report covers a descriptive overview and comprehensive insight of the Gonorrhea Epidemiology and Gonorrhea  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Gonorrhea market report provides insights on the current and emerging therapies.
  3. Gonorrhea market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Gonorrhea market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Gonorrhea market.

Got queries? Click here to know more about the Gonorrhea Market Landscape.

Gonorrhea Market 

The dynamics of the Gonorrhea market are anticipated to change in the coming years owing to the expected launch of emerging therapies by key companies such as Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics, and others during the forecasted period 2019-2032.

Gonorrhea Pipeline Therapies and Key Companies 

  • EVO100: Evofem Biosciences
  • Gepotidacin (GSK2140944): GlaxoSmithKline
  • Zoliflodacin (ETX0914): Entasis/GARDP
  • And others.

Gonorrhea Market Drivers 

  • Increasing prevalence of Gonorrhea
  • Improved awareness on Gonorrhea

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Gonorrhea Patient Share (%) Overview at a Glance

5. Gonorrhea Market Overview at a Glance

6. Gonorrhea Disease Background and Overview

7. Gonorrhea Epidemiology and Patient Population

8. Country-Specific Patient Population of Gonorrhea 

9. Gonorrhea Current Treatment and Medical Practices

10. Unmet Needs

11. Gonorrhea Emerging Therapies

12. Gonorrhea Market Outlook

13. Country-Wise Gonorrhea Market Analysis (2019–2032)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Gonorrhea Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Gonorrhea Market Outlook 2032.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/